Free Trial

Enfusion (ENFN) SEC Filings & 10K Form

Enfusion logo
$9.89 +0.25 (+2.59%)
(As of 11/20/2024 ET)

Recent Enfusion SEC Filings

DateFilerForm TypeView
11/04/2024
3:15 PM
Enfusion (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
7:15 AM
Enfusion (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
6:13 PM
Enfusion (Subject)
Malherbe Investments LLC (Filed by)
Form SC 13G/A
10/25/2024
3:30 PM
Enfusion (Subject)
LRA Ventures, LLC (Filed by)
Form SC 13G/A
10/24/2024
3:15 PM
Campobasso Matthew (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
2:43 PM
Campobasso Matthew (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:15 PM
Bastone Bronwen (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
2:16 PM
Bastone Bronwen (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2024
2:32 PM
BROWN CAPITAL MANAGEMENT LLC (Filed by)
Enfusion (Subject)
Form SC 13G/A
08/06/2024
3:16 PM
Enfusion (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
6:45 AM
Enfusion (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
5:38 PM
Bastone Bronwen (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
5:39 PM
Campobasso Matthew (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
5:40 PM
Enfusion (Issuer)
Gutowski Valeria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:19 PM
Bastone Bronwen (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
2:45 PM
Campobasso Matthew (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
2:50 PM
Bastone Bronwen (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
8:08 PM
Enfusion (Issuer)
LEIBOWITZ LAWRENCE E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
8:10 PM
DeRose Kathleen (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
8:11 PM
Enfusion (Issuer)
Hauser Jan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
8:12 PM
Enfusion (Issuer)
Spellacy Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
8:14 PM
Enfusion (Issuer)
Somers Deirdre (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
2:16 PM
Enfusion (Subject)
Somers Deirdre (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/22/2024
2:36 PM
Bastone Bronwen (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
3:29 PM
Bastone Bronwen (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2024
6:45 AM
Enfusion (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
3:25 PM
Enfusion (Filer)
Form ARS
04/26/2024
3:20 PM
Enfusion (Filer)
Form DEFA14A
04/26/2024
3:15 PM
Enfusion (Filer)
Form DEF 14A
03/19/2024
5:30 AM
Enfusion (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
3:16 PM
Enfusion (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2024
7:45 AM
Enfusion (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
7:45 AM
Enfusion (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
4:15 PM
CSL Tech Holdings LLC (Reporting)
Enfusion (Issuer)
Movchan Oleg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:24 PM
Enfusion (Issuer)
Gutowski Valeria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:25 PM
Enfusion (Issuer)
Pawar Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:26 PM
CSL Tech Holdings LLC (Reporting)
Enfusion (Issuer)
Movchan Oleg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:20 PM
Bastone Bronwen (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:21 PM
Campobasso Matthew (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:23 PM
Enfusion (Issuer)
Herring Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:35 PM
Campobasso Matthew (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Tesla Execs are Freaking Out (Ad)

It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.

03/04/2024
6:32 PM
Enfusion (Issuer)
Gutowski Valeria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
2:22 PM
Campobasso Matthew (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
3:46 PM
Enfusion (Subject)
Groman Dan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/15/2024
3:46 PM
Enfusion (Subject)
Groman Dan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
5:08 AM
Enfusion (Subject)
Werner Capital LLC (Filed by)
Form SC 13G/A
02/07/2024
7:00 AM
Enfusion (Subject)
LRA Ventures, LLC (Filed by)
Form SC 13G/A
01/24/2024
3:20 PM
Enfusion (Subject)
Groman Dan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2024
3:31 PM
Enfusion (Subject)
Groman Dan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
3:40 PM
Enfusion (Subject)
Groman Dan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/19/2024
4:25 PM
Enfusion (Issuer)
Gutowski Valeria (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/18/2024
7:20 AM
Enfusion (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2024
6:00 PM
Enfusion (Issuer)
Somers Deirdre (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
7:00 PM
Bastone Bronwen (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
7:01 PM
Enfusion (Issuer)
Herring Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
7:02 PM
Campobasso Matthew (Reporting)
Enfusion (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
7:02 PM
CSL Tech Holdings LLC (Reporting)
Enfusion (Issuer)
Movchan Oleg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
2:15 PM
Enfusion (Subject)
Somers Deirdre (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:27 PM
Enfusion (Subject)
Movchan Oleg (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:28 PM
Enfusion (Subject)
Herring Bradley (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:13 PM
Bastone Bronwen (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:15 PM
Enfusion (Subject)
Groman Dan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:23 PM
Campobasso Matthew (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
8:18 AM
Enfusion (Subject)
Herring Bradley (Reporting)
Form 144/A
01/08/2024
3:27 PM
Enfusion (Subject)
Groman Dan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:35 PM
Enfusion (Subject)
Movchan Oleg (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:22 PM
Campobasso Matthew (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:22 PM
Bastone Bronwen (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:24 PM
Enfusion (Subject)
Herring Bradley (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2023
6:00 PM
CSL Tech Holdings LLC (Reporting)
Enfusion (Issuer)
Movchan Oleg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
1:08 PM
Enfusion (Subject)
Groman Dan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/05/2023
6:00 PM
CSL Tech Holdings LLC (Reporting)
Enfusion (Issuer)
Movchan Oleg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
3:00 PM
CSL Tech Holdings LLC (Reporting)
Enfusion (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2023
6:03 PM
Campobasso Matthew (Reporting)
Enfusion (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/29/2023
6:04 PM
Enfusion (Issuer)
Pawar Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
6:01 PM
Enfusion (Issuer)
Pawar Neal (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/28/2023
5:00 PM
Enfusion (Issuer)
Malherbe Investments LLC (Reporting)
Malherbe Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
7:25 AM
Enfusion (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:ENFN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners